Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-08-2017 | Letter to the Editor (by invitation)

Author’s reply: Re: Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong

Authors: Alex Lap-Ki Ng, Patrick Siu-Hung Li, Kenneth Kai-Wang Li

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 8/2017

Excerpt

Dear Editor, …

Ng AL, Tang WW, Li PS, Li KK (2016) Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol 254:1987–1992. doi:10.1007/s00417-016-3473-0 CrossRefPubMed

Haripriya A, Chang DF, Ravindran RD (2017) Endophthalmitis reduction with Intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries. Ophthalmology. doi:10.1016/j.ophtha.2017.01.026

Garg P, Roy A, Sharma S (2017) Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol 28:67–72. doi:10.1097/ICU.0000000000000326 CrossRefPubMed

Tan CS, Wong HK, Yang FP (2012) Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agents. J Cataract Refract Surg 38:425–430. doi:10.1016/j.jcrs.2011.09.040 CrossRefPubMed

Yannuzzi NA, Si N, Relhan N, Kuriyan AE, Albini TA, Berrocal AM, Davis JL, Smiddy WE, Townsend J, Miller D, Flynn HW Jr (2017) Endophthalmitis after clear corneal cataract surgery: outcomes over two decades. Am J Ophthalmol 174:155–159. doi:10.1016/j.ajo.2016.11.006 CrossRefPubMed

Lundstrom M, Friling E, Montan P (2015) Risk factors for endophthalmitis after cataract surgery: predictors for causative organisms and visual outcomes. J Cataract Refract Surg 41:2410–2416. doi:10.1016/j.jcrs.2015.05.027 CrossRefPubMed

Sharifi E, Porco TC, Naseri A (2009) Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology 116:1887–1896.e1881. doi:10.1016/j.ophtha.2009.03.014 CrossRefPubMed

Title: Author’s reply: Re: Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong
Authors: Alex Lap-Ki Ng
Patrick Siu-Hung Li
Kenneth Kai-Wang Li
Publication date: 01-08-2017
Publisher: Springer Berlin Heidelberg
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2017
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-017-3688-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Author’s reply: Re: Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2017

Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye

Challenges with cataract surgery in pars planitis patients

Ciliary body thickness changes after preoperative anti-inflammatory treatment in rhegmatogenous retinal detachment complicated by choroidal detachment

Ranibizumab for choroidal neovascularization secondary to pseudoxanthoma elasticum: 4-year results from the PIXEL study in France

Long-term follow-up of fellow eye in patients with lamellar macular hole